Compare NEXN & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEXN | SLP |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.2M | 322.4M |
| IPO Year | 2021 | 1997 |
| Metric | NEXN | SLP |
|---|---|---|
| Price | $6.66 | $19.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $12.13 | ★ $27.25 |
| AVG Volume (30 Days) | ★ 361.0K | 355.1K |
| Earning Date | 11-13-2025 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 237.45 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $376,353,000.00 | $79,179,000.00 |
| Revenue This Year | $5.43 | $2.02 |
| Revenue Next Year | N/A | $6.92 |
| P/E Ratio | $10.51 | ★ N/A |
| Revenue Growth | 7.80 | ★ 13.09 |
| 52 Week Low | $6.08 | $12.39 |
| 52 Week High | $12.60 | $37.67 |
| Indicator | NEXN | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 56.71 |
| Support Level | $6.40 | $17.74 |
| Resistance Level | $6.95 | $19.62 |
| Average True Range (ATR) | 0.22 | 0.72 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 38.81 | 53.23 |
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.